https://www.avient.com/products/engineered-polymer-formulations/general-engineered-formulations/edgetek-3d/lds-solutions
Edgetek 3D/LDS solutions are advanced technologies to help customers to build 3D circuits on molded part surfaces, which are widely used for consumer electronics, automotive components, medical devices, and 5G base stations.
https://www.avient.com/investor-center/news/polyone-board-elects-robert-abernathy-director
a medical technology company specializing in eliminating pain, speeding recovery and preventing infections for healthcare providers and patients worldwide.
https://www.avient.com/news/polyone-features-innovative-packaging-technologies-and-inspiration-pack-expo-2015
Valiant™ medical-grade packaging rollstock
https://www.avient.com/news/bio-based-tpe-biopharmaceutical-tubing-added-avient-s-sustainable-healthcare-solutions
The 71 Shore A formulation provides critical application performance such as weldability, kink resistance, and tensile strength comparable to leading medical tubing materials, including silicone and standard TPEs.
https://www.avient.com/idea/comparing-sustainable-tpes-traditional-alternatives
pacifiers, baby bottle nipples, etc.) and medical applications (i.e., catheters, syringe seals, respiratory masks, etc.).
https://www.avient.com/sites/default/files/2020-08/silcosperse-lm-product-bulletin-v2.pdf
KEY CHARACTERISTICS
• Provides laser marking options
of silicone materials
• Eliminates the needs for etching
and embossing
• Faster and cleaner than pad printing
• High contrast, permanent markings
• Mechanical properties of the silicone matrix
are maintained
• Compatible with various types of lasers
• Chemically resistant
• Available in pre-colored or natural
MARKETS AND APPLICATIONS
Silcosperse LM Laser Marking additive dispersions
are suitable for a variety of applications within
industries such as:
• Consumer Goods
• Electronics
• Healthcare
• Industrial
• Transportation
• Wire & Cable
Typical applications and purposes include:
• Traceability, UPC bar-coding, branding
• Unique Device Identification (UDI),
medical device ID’s
• Serialization for pharmaceutical packaging
• Safety taggants & equipment
• Automotive components
• Wire & cable part numbers or gauge size
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2023-11/Cesa Fiber Additives Hydrophobic for PP Nonwovens Product Bulletin.pdf
APPLICATIONS
• Construction: roofing underlay, cable wrapping,
geotextiles
• Medical: surgical gowns, surgical drapes, sterile
tray wraps, hospital bed sheets, and curtains
• Filtration: various filters that require water
repellency
BENEFITS
• Fast and long-lasting water repellency
• IPA repellency grade 6
• No visible influence on the final color of the
nonwoven fabric
• Can be combined with color into a single
product for convenience
• Regulatory compliance to key standards and
support for specific standards
PRODUCT BULLETIN
Copyright © 2023, Avient Corporation.
https://www.avient.com/sites/default/files/2022-09/Cesa Scratch _ Mar Resistance Additives Product Bulletin.pdf
It is suitable for high-
wear or high-touch environments such as:
• Automotive interior components
• Small appliances
• Consumer & handheld electronics
• Medical devices
• Consumer & cosmetic packaging
www.avient.com
Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/resources/POL%2520Gabelli%2520IR%2520Presentation%2520w%2520Non-GAAP%252003%252020%25202014.pdf
Use of Non-GAAP Measures
Page 3
PolyOne Commodity to Specialty Transformation
Page 4
• Continue specialty
transformation
• Targeting $2.50
Adjusted EPS by
2015, nearly
double 2013 EPS
• Drive double digit
operating income
and adjusted EPS
growth
• 17 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Steve Newlin
Appointed,
Chairman, President
and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2013 2014 and beyond
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500 Russell 2000 Dow Jones Chemical
All time high of
$38.38
March 7th, 2014
• 17 consecutive quarters of
double digit EPS growth
• 49% CAGR adjusted EPS
expansion 2006-2013
• 2013 stock price increased
73% versus 30% growth in the
S&P
• More than seven fold increase in
market cap: $0.5b $3.6b
Strategy and Execution Drive Results
Page 5
Appliance
4%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
5%
Consumer
10%Packaging
16%
Industrial
12%
HealthCare
11%
Transportation
18%
Misc.
2%
United
States
66%
Europe
14%
Canada
7%
Asia
6%
Latin
America
7%
PP&S
Specialty
53%
Distribution
27%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
1.31
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010 2011 2012 2013 2015
Target
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
ha
re
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
EPS
Page 6
PolyOne
At A Glance
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34% 43%
62%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
Specialty OI $5M $46M $87M $195M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 2013 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 9.3% 12 – 16%
Designed Structures & Solutions -- 5.6% 8 – 10%
Performance Products &
Solutions 5.4% 7.2% 9 – 12%
Distribution 2.6% 5.9% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.1% 15%
4) Adjusted EPS Growth N/A 31% Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
Bridge To $2.50 Adjusted EPS By 2015
2015 EPS: $2.50
2013 EPS: $1.31
Mid single digit
revenue CAGR
Page 9
Mergers & Acquisitions
Spartech accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation &
Mix Improvement
Innovation Drives Earnings Growth
$20.3
$52.3
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 10
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 11
Unique and Innovative Solutions that Help
Customers Win
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
Net Debt / EBITDA* = 1.8x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of December 31, 2013
($ millions)
Page 12
Coupon Rates: 7.500% 7.375% 5.250%
Debt Maturities & Pension Funding – 12/31/13
*TTM 12/31/2013 ** includes US-qualified plans only
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2013
Pension Funding**
As of December 31, 2013
Free Cash Flow and Strong Balance Sheet Fund Investment
•Targets that expand our:
• Specialty offerings
•End market presence
•Geographic footprint
•Operating Margin
• Synergy opportunities
•Adjacent material solutions
•Expanding our sales,
marketing, and technical
capabilities
• Investing in operational and
LSS initiatives (including
synergy capture)
•Manufacturing alignment Organic
Growth
Share
Repurchases
Dividends
Acquisitions
Page 13
$0.16
$0.20 $0.24
$0.32
$0.00
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
• Repurchased ~5 million
shares in 2013
• 15 million shares
are available for
repurchase under
the current
authorization
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Why Invest In PolyOne?
https://www.avient.com/resources/safety-data-sheets?page=5654
Geon(TM) V1821 WHITE FLUID BED PVC